1. Home
  2. CCCC vs IPI Comparison

CCCC vs IPI Comparison

Compare CCCC & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • IPI
  • Stock Information
  • Founded
  • CCCC 2015
  • IPI 2000
  • Country
  • CCCC United States
  • IPI United States
  • Employees
  • CCCC N/A
  • IPI N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • CCCC Health Care
  • IPI Industrials
  • Exchange
  • CCCC Nasdaq
  • IPI Nasdaq
  • Market Cap
  • CCCC 304.8M
  • IPI 309.4M
  • IPO Year
  • CCCC 2020
  • IPI 2008
  • Fundamental
  • Price
  • CCCC $6.03
  • IPI $24.27
  • Analyst Decision
  • CCCC Buy
  • IPI Hold
  • Analyst Count
  • CCCC 7
  • IPI 1
  • Target Price
  • CCCC $8.71
  • IPI $23.00
  • AVG Volume (30 Days)
  • CCCC 2.6M
  • IPI 74.0K
  • Earning Date
  • CCCC 08-06-2024
  • IPI 07-31-2024
  • Dividend Yield
  • CCCC N/A
  • IPI N/A
  • EPS Growth
  • CCCC N/A
  • IPI N/A
  • EPS
  • CCCC N/A
  • IPI N/A
  • Revenue
  • CCCC $20,036,000.00
  • IPI $271,450,000.00
  • Revenue This Year
  • CCCC $26.24
  • IPI N/A
  • Revenue Next Year
  • CCCC N/A
  • IPI $4.92
  • P/E Ratio
  • CCCC N/A
  • IPI N/A
  • Revenue Growth
  • CCCC N/A
  • IPI N/A
  • 52 Week Low
  • CCCC $1.06
  • IPI $17.52
  • 52 Week High
  • CCCC $11.88
  • IPI $28.30
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 57.54
  • IPI 50.90
  • Support Level
  • CCCC $4.36
  • IPI $24.23
  • Resistance Level
  • CCCC $7.66
  • IPI $26.39
  • Average True Range (ATR)
  • CCCC 0.56
  • IPI 0.74
  • MACD
  • CCCC 0.21
  • IPI 0.20
  • Stochastic Oscillator
  • CCCC 50.68
  • IPI 47.39

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: